PDT Partners’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.68M | Sell |
190,983
-126,482
| -40% | -$1.77M | 0.15% | 235 |
|
|
2025
Q1 | $4.97M | Sell |
317,465
-2,250
| -0.7% | -$35.2K | 0.35% | 72 |
|
|
2024
Q4 | $4.45M | Hold |
319,715
| – | – | 0.39% | 52 |
|
|
2024
Q3 | $2.97M | Hold |
319,715
| – | – | 0.26% | 118 |
|
|
2024
Q2 | $2.97M | Sell |
319,715
-511
| -0.2% | -$4.75K | 0.28% | 112 |
|
|
2024
Q1 | $3.17M | Buy |
+320,226
| New | +$3.17M | 0.3% | 102 |
|
|
2023
Q4 | – | Sell |
-195,081
| Closed | -$1.04M | – | 541 |
|
|
2023
Q3 | $1.04M | Buy |
195,081
+74,503
| +62% | +$396K | 0.13% | 275 |
|
|
2023
Q2 | $1.15M | Sell |
120,578
-34,906
| -22% | -$333K | 0.16% | 218 |
|
|
2023
Q1 | $1.71M | Buy |
155,484
+97,607
| +169% | +$1.07M | 0.23% | 155 |
|
|
2022
Q4 | $857K | Buy |
57,877
+45,204
| +357% | +$669K | 0.14% | 267 |
|
|
2022
Q3 | $242K | Buy |
+12,673
| New | +$242K | 0.04% | 656 |
|